• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PIK3IP1:在疾病中的结构、异常、功能和调控。

PIK3IP1: structure, aberration, function, and regulation in diseases.

机构信息

Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.

出版信息

Eur J Pharmacol. 2024 Aug 15;977:176753. doi: 10.1016/j.ejphar.2024.176753. Epub 2024 Jun 17.

DOI:10.1016/j.ejphar.2024.176753
PMID:38897445
Abstract

Phosphoinositide 3-kinase (PI3K) pathway, controlling diverse functions in cells, is one of the most frequently dysregulated pathways in cancer. Several negative regulators have been reported to intricately constrain the overactivation of PI3K pathway. Phosphatidylinoinosidine-3-kinase interacting protein 1 (PIK3IP1), as a unique transmembrane protein, is a newly discovered negative regulator of PI3K pathway. PIK3IP1 negatively regulates PI3K activity by directly binding to the p110 catalytic subunit of PI3K. It has been reported that PIK3IP1 is frequently low expressed in tumors and autoimmune diseases. In tumor cells and impaired cardiomyocyte, PIK3IP1 inhibits cell proliferation and survival. Consistently, the expression of PIK3IP1 is related with the condition of cancer. In addition, PIK3IP1 inhibits the inflammatory response and immune function via maintaining the quiescent state of immune cells. Thus, low expression of PIK3IP1 represents the severe condition of autoimmune diseases. PIK3IP1 is regulated by transcription factors, epigenetic factors or micro-RNAs to facilitate its normal function in different cellular contexts. This review integrates the total findings on PIK3IP1 in different disease, and summaries the structure, biological functions and regulatory mechanisms of PIK3IP1.

摘要

磷酸肌醇 3-激酶(PI3K)途径,控制细胞中的多种功能,是癌症中最常失调的途径之一。已经报道了几种负调控因子来精细地限制 PI3K 途径的过度激活。磷脂酰肌醇-3-激酶相互作用蛋白 1(PIK3IP1)作为一种独特的跨膜蛋白,是 PI3K 途径的一种新发现的负调控因子。PIK3IP1 通过直接与 PI3K 的 p110 催化亚基结合,负调控 PI3K 的活性。已经报道 PIK3IP1 在肿瘤和自身免疫性疾病中经常低表达。在肿瘤细胞和受损的心肌细胞中,PIK3IP1 抑制细胞增殖和存活。一致地,PIK3IP1 的表达与癌症的状况有关。此外,PIK3IP1 通过维持免疫细胞的静止状态来抑制炎症反应和免疫功能。因此,PIK3IP1 的低表达代表自身免疫性疾病的严重状况。PIK3IP1 受转录因子、表观遗传因子或 micro-RNAs 的调节,以促进其在不同细胞环境中的正常功能。本综述综合了 PIK3IP1 在不同疾病中的研究结果,总结了 PIK3IP1 的结构、生物学功能和调节机制。

相似文献

1
PIK3IP1: structure, aberration, function, and regulation in diseases.PIK3IP1:在疾病中的结构、异常、功能和调控。
Eur J Pharmacol. 2024 Aug 15;977:176753. doi: 10.1016/j.ejphar.2024.176753. Epub 2024 Jun 17.
2
PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma.PIK3IP1是PI3K的负调控因子,可抑制肝细胞癌的发展。
Cancer Res. 2008 Jul 15;68(14):5591-8. doi: 10.1158/0008-5472.CAN-08-0025.
3
PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein.PI3K受PIK3IP1负调控,PIK3IP1是一种新型的与p110相互作用的蛋白。
Biochem Biophys Res Commun. 2007 Jun 22;358(1):66-72. doi: 10.1016/j.bbrc.2007.04.096. Epub 2007 Apr 24.
4
Pik3ip1 modulates cardiac hypertrophy by inhibiting PI3K pathway.Pik3ip1通过抑制PI3K信号通路来调节心肌肥大。
PLoS One. 2015 Mar 31;10(3):e0122251. doi: 10.1371/journal.pone.0122251. eCollection 2015.
5
Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity.Pik3ip1 是一种负性免疫调节因子,可抑制抗肿瘤 T 细胞免疫。
Clin Cancer Res. 2019 Oct 15;25(20):6180-6194. doi: 10.1158/1078-0432.CCR-18-4134. Epub 2019 Jul 26.
6
Inhibition of T-cell activation by PIK3IP1.PIK3IP1 抑制 T 细胞活化。
Eur J Immunol. 2012 Oct;42(10):2754-9. doi: 10.1002/eji.201141653. Epub 2012 Jul 19.
7
Regulation of autoimmune disease progression by Pik3ip1 through metabolic reprogramming in T cells and therapeutic implications.通过 T 细胞代谢重编程调节 Pik3ip1 控制自身免疫性疾病进展及治疗意义
Sci Adv. 2022 Sep 30;8(39):eabo4250. doi: 10.1126/sciadv.abo4250.
8
PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt.PIK3IP1/TrIP 通过抑制 PI3K/Akt 来限制 T 细胞的激活。
J Exp Med. 2018 Dec 3;215(12):3165-3179. doi: 10.1084/jem.20172018. Epub 2018 Nov 14.
9
PIK3IP1 Promotes Extrafollicular Class Switching in T-Dependent Immune Responses.PIK3IP1 促进 T 依赖性免疫应答中的滤泡外类别转换。
J Immunol. 2020 Oct 15;205(8):2100-2108. doi: 10.4049/jimmunol.2000584. Epub 2020 Sep 4.
10
CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.环状磷酸二酯酶5A编码的PI3K/AKT通路新型调节因子通过促进USP14介导的PIK3IP1去泛素化抑制食管鳞状细胞癌进展。
J Exp Clin Cancer Res. 2024 Apr 24;43(1):124. doi: 10.1186/s13046-024-03054-3.

引用本文的文献

1
Using proteomic biomarkers to estimate acute ischaemic stroke onset time.利用蛋白质组学生物标志物估计急性缺血性中风发病时间。
Commun Med (Lond). 2025 May 17;5(1):183. doi: 10.1038/s43856-025-00895-7.
2
Promoting collagen synthesis: a viable strategy to combat skin ageing.促进胶原蛋白合成:对抗皮肤衰老的可行策略。
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2488821. doi: 10.1080/14756366.2025.2488821. Epub 2025 Apr 11.